Related references
Note: Only part of the references are listed.Role of nucleosornal occupancy in the epigenetic silencing of the MLH1 CpG island
Joy C. Lin et al.
CANCER CELL (2007)
High-resolution profiling of histone methylations in the human genome
Artern Barski et al.
CELL (2007)
Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes
Yi Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
Jing Tan et al.
GENES & DEVELOPMENT (2007)
Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas
Masanobu Abe et al.
CANCER LETTERS (2007)
DNA methylation as a therapeutic target in cancer
Jean-Pierre J. Issa
CLINICAL CANCER RESEARCH (2007)
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome
Nathaniel D. Heintzman et al.
NATURE GENETICS (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells
Amaia Lujambio et al.
CANCER RESEARCH (2007)
Epigenetic stem cell signature in cancer
Martin Widschwendter et al.
NATURE GENETICS (2007)
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer
Yeshayahu Schlesinger et al.
NATURE GENETICS (2007)
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing
Joyce E. Ohm et al.
NATURE GENETICS (2007)
Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome
Michael Weber et al.
NATURE GENETICS (2007)
Mapping the cancer genome - Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies
Francis S. Collins et al.
SCIENTIFIC AMERICAN (2007)
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia
Hagop Kantarjian et al.
BLOOD (2007)
The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia
Joseph R. Dobosy et al.
JOURNAL OF UROLOGY (2007)
The role of RASSF1A methylation in cancer
Luke B. Hesson et al.
DISEASE MARKERS (2007)
Cancer epigenomics: DNA methylomes and histone-modification maps
Manel Esteller
NATURE REVIEWS GENETICS (2007)
DNA methylation profiling of human chromosomes 6, 20 and 22
Florian Eckhardt et al.
NATURE GENETICS (2006)
Genome-wide high-resolution mapping and functional analysis of DNA methylation in Arabidopsis
Xiaoyu Zhang et al.
CELL (2006)
Nutrient regulates Tor1 nuclear localization and association with rDNA promoter
Hong Li et al.
NATURE (2006)
MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells
Tibor Rauch et al.
CANCER RESEARCH (2006)
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
Daniel J. Weisenberger et al.
NATURE GENETICS (2006)
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells
Yoshimasa Saito et al.
CANCER CELL (2006)
Polycomb complexes repress developmental regulators in murine embryonic stem cells
LA Boyer et al.
NATURE (2006)
Control of developmental regulator's by polycomb in human embryonic stem cells
TI Lee et al.
CELL (2006)
Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort
SA Belinsky et al.
CANCER RESEARCH (2006)
High-throughput DNA methylation profiling using universal bead arrays
M Bibikova et al.
GENOME RESEARCH (2006)
Evidence for an instructive mechanism of de novo methylation in cancer cells
I Keshet et al.
NATURE GENETICS (2006)
Epigenetic therapy of cancer: past, present and future
CB Yoo et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
A blueprint for a human epigenome project: the AACR human epigenome workshop
PA Jones et al.
CANCER RESEARCH (2005)
Loss of imprinting of IGF2:: A common epigenetic modifier of intestinal tumor risk
A Kaneda et al.
CANCER RESEARCH (2005)
Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells
M Weber et al.
NATURE GENETICS (2005)
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
MF Fraga et al.
NATURE GENETICS (2005)
Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing
KN Harikrishnan et al.
NATURE GENETICS (2005)
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway
A Insinga et al.
NATURE MEDICINE (2005)
High-resolution genome-wide mapping of histone modifications
TY Roh et al.
NATURE BIOTECHNOLOGY (2004)
Preferential response of cancer cells to zebularine
JC Cheng et al.
CANCER CELL (2004)
Epigenetics in human disease and prospects for epigenetic therapy
G Egger et al.
NATURE (2004)
Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome
GN Liang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Chromosomal instability and tumors promoted by DNA hypomethylation
A Eden et al.
SCIENCE (2003)
Induction of tumors in mice by genomic hypomethylation
F Gaudet et al.
SCIENCE (2003)
The power and the promise of DNA methylation markers
PW Laird
NATURE REVIEWS CANCER (2003)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer
H Suzuki et al.
NATURE GENETICS (2002)
Quantitative methylation analysis using methylation-sensitive single-nucleotide primer extension (Ms-SNuPE)
ML Gonzalgo et al.
METHODS (2002)
Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer
RW Johnstone
NATURE REVIEWS DRUG DISCOVERY (2002)
Comprehensive analysis of CpG islands in human chromosomes 21 and 22
D Takai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation
VM Richon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
MethyLight: a high-throughput assay to measure DNA methylation
Cindy A. Eads et al.
NUCLEIC ACIDS RESEARCH (2000)
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
JF Costello et al.
NATURE GENETICS (2000)
Share Paper
